威尔逊病患者的饮食质量和营养风险:一个横截面研究
Shou-Hong Lin1, Mei-Ling Yang1, Yi Zeng1
1Department of Neurology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Frontiers in nutrition
|September 29, 2025
概括
患有威尔逊病的患者饮食质量差,营养风险高. 较低的饮食质量评分独立预测营养不良,强调需要饮食评估和干预.
科学领域:
- 营养科学 营养科学
- 临床医学 临床医学
- 罕见疾病 罕见疾病
背景情况:
- 威尔逊病 (WD) 是一种罕见的遗传疾病,影响铜代谢.
- 饮食因素可以显著影响慢性病患者的健康结果.
- 评估饮食质量和营养风险对于管理WD患者至关重要.
研究的目的:
- 为了评估威尔逊病患者的饮食质量.
- 为了确定与低于最佳的饮食质量相关的因素.
- 研究WD患者的饮食质量与营养风险之间的关系.
主要方法:
- 在91名WD患者的横截面研究.
- 使用国际饮食质量指数 (DQI-I) 评估饮食质量.
- 用小型营养评估 (MNA) 评估的营养风险.
- 进行了逻辑和线性回归分析.
主要成果:
- 74.7%的WD患者营养不良或有营养不良的风险.
- 较低的DQI-I得分与女性性别,教育程度较低,疾病持续时间较长和吸烟有关.
- 低于最佳的饮食质量 (DQI-I ≤61) 显著预测了营养不良和营养风险的增加风险,即使在多变量调整后.
结论:
- 威尔逊病患者经常饮食质量差,营养风险高.
- 饮食质量评估对于识别WD中的营养不良风险非常有价值.
- 建议以饮食师为主导的有针对性的干预措施来改善结果.
相关概念视频
Chronic Kidney Disease III: Interprofessional Care
344
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
344
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
643
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
643
Bioavailability Study Design: Healthy Subjects Versus Patients
144
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
144
Chronic Kidney Disease II: Clinical Manifestations
555
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
555
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
185
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
185
Therapeutic Drug Monitoring: Affecting Factors
201
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
201


